📣 VC round data is live. Check it out!

Insight Lifetech Valuation Multiples

Discover revenue and EBITDA valuation multiples for Insight Lifetech and similar public comparables like Amplifon, BGI Genomics, Mehow Innovative, Integer Holdings and more.

Insight Lifetech Overview

About Insight Lifetech

Insight Lifetech Co Ltd is a medtech company. It is engaged in the research and development, production, and sale of medical devices used in the diagnosis and treatment of cardiovascular diseases. The company's core products are the TruePhysio pressure microcatheter and VivoCardio FFR system.


Founded

2015

HQ

China

Employees

N/A

Financials (FY)

Revenue: $80M
EBITDA: $18M

EV

$3B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Insight Lifetech Financials

Insight Lifetech reported last fiscal year revenue of $80M and EBITDA of $18M.

In the same fiscal year, Insight Lifetech generated $56M in gross profit, $18M in EBITDA, and $12M in net income.


Insight Lifetech P&L

In the most recent fiscal year, Insight Lifetech reported revenue of $80M and EBITDA of $18M.

Insight Lifetech is profitable as of last fiscal year, with gross margin of 70%, EBITDA margin of 22%, and net margin of 15%.

See analyst estimates for Insight Lifetech
Last FY20242025202620272028
Revenue$80M$47M$80M
Gross Profit$56M$29M$56M
Gross Margin70%63%70%
EBITDA$18M($4M)$18M
EBITDA Margin22%(10%)22%
EBIT Margin15%(23%)15%
Net Profit$12M($6M)$12M
Net Margin15%(14%)15%

Financial data powered by Morningstar, Inc.

Insight Lifetech Stock Performance

Insight Lifetech has current market cap of $3B, and enterprise value of $3B.

Market Cap Evolution


Insight Lifetech's stock price is $6.73.

Insight Lifetech share price increased by 10.5% in the last 30 days.

Insight Lifetech has an EPS (earnings per share) of $0.03.

See more trading valuation data for Insight Lifetech
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$3B$3B1.3%10.5%11.5%$0.03

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Insight Lifetech Valuation Multiples

Insight Lifetech trades at 33.2x EV/Revenue multiple, and 149.3x EV/EBITDA.

See NTM and 2027E valuation multiples for Insight Lifetech

Insight Lifetech Financial Valuation Multiples

As of May 12, 2026, Insight Lifetech has market cap of $3B and EV of $3B.

Insight Lifetech has a P/E ratio of 238.7x.

Last FY202320242025202620272028
EV/Revenue33.2x56.8x33.2x
EV/EBITDA149.3xn/m149.3x
EV/EBIT223.4x(249.9x)223.4x
EV/Gross Profit47.5x89.7x47.5x
P/E238.7xn/m238.7x
EV/FCF156.5x(115.9x)n/m156.5x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Insight Lifetech Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Insight Lifetech Margins & Growth Rates

In the most recent fiscal year, Insight Lifetech reported gross margin of 70%, EBITDA margin of 22%, and net margin of 15%.

See estimated margins and future growth rates for Insight Lifetech

Insight Lifetech Margins

Last FY20242025202720282029
Gross Margin70%63%70%
EBITDA Margin22%(10%)22%
EBIT Margin15%(23%)15%
Net Margin15%(14%)15%
FCF Margin21%4%21%

Insight Lifetech Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth71%
Gross Profit Growth89%
EBITDA Growth(500%)
EBIT Growth(212%)
Net Profit Growth(284%)
FCF Growth(108%)776%

Data powered by FactSet, Inc. and Morningstar, Inc.

Insight Lifetech Operational KPIs

Access forward-looking KPIs for Insight Lifetech
Last FY20242025202620272028
S&M Expenses to Revenue12%16%12%
G&A Expenses to Revenue6%7%6%
R&D Expenses to Revenue16%32%16%
Opex to Revenue55%86%55%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Insight Lifetech Competitors

Insight Lifetech competitors include Amplifon, BGI Genomics, Mehow Innovative, Integer Holdings, Autobio Diagnostics, Carl Zeiss Meditec, GRAIL, 10x Genomics, Ambu and Double Medical Technology.

Most Insight Lifetech public comparables operate across Medical Devices, Diagnostics & Genomics, BioTech and DeepTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Amplifon1.6x1.6x7.4x7.2x
BGI Genomics4.3x4.3x54.6x50.6x
Mehow Innovative10.5x9.6x39.5x36.5x
Integer Holdings2.3x2.3x10.6x10.8x
Autobio Diagnostics4.5x4.4x11.2x11.4x
Carl Zeiss Meditec1.1x1.1x6.5x6.9x
GRAIL12.6x11.7x(4.9x)(5.1x)
10x Genomics3.3x3.4x548.4x(49.9x)

This data is available for Pro users. Sign up to see all Insight Lifetech competitors and their valuation data.

Start Free Trial

Insight Lifetech Funding History

Before going public, Insight Lifetech raised $159M in total equity funding, across 4 rounds.


Insight Lifetech Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Jul-21Series DQiming Venture Partners$85MInsight Lifetech is a leading Chinese innovative medical device manufacturer focused on intelligence-powered precision cardiovascular intervention, addressing coronary artery diseases, peripheral vascular diseases, and atrial fibrillation. The company has developed 11 products brought to market, including IVUS systems, FFR systems, vascular access products, and electrophysiological solutions, filling critical gaps in China's high-tech medical device sector. Qiming Venture Partners led Insight Lifetech's C round financing in 2020 and participated in the subsequent D round, holding over 6% stake pre-IPO as a major institutional investor. Insight Lifetech successfully listed on the Shanghai Stock Exchange's STAR Market on February 5, 2026 (688712.SH), issuing shares at CNY17.52 per share, opening at CNY50.31, with a market capitalization of CNY20.98 billion and raising approximately ¥998.64 million (US$143.93 million) via an unprofitable biotech track. The IPO validates the company's development in domestic cardiovascular innovative medical devices and highlights China's rising global competitiveness in medtech. Qiming Venture Partners views China's clinical experience, engineering capabilities, supply chains, and entrepreneurship as key to building worldwide-competitive medical device products. The company adheres to its mission of transforming healthcare through innovation and quality, with founder Song Liang emphasizing relentless efforts in high-performance precision devices.
May-21Secondary - privateQiming Venture Partners$18M
Dec-20Series CHSG; Qiming Venture Partners; SDIC Unity Capital; Taiyu Investment$28MInsight Lifetech is a leading Chinese innovative medical device manufacturer based in Shenzhen, founded in 2015, specializing in precision cardiovascular intervention products. The company successfully listed on the Shanghai Stock Exchange's STAR Market (688712.SH) on February 5, 2026, issuing shares at CNY17.52 per share and opening at CNY50.31 per share with a market capitalization of CNY20.98 billion. Qiming Venture Partners led the company's Series C financing in 2020 and participated in the subsequent Series D round, holding more than 6% stake pre-IPO as a major institutional investor. Insight Lifetech has raised a total of $42.73 million across three funding rounds, including Series B in April 2020 led by SDIC and the Series C. Post-IPO, Insight Lifetech continues to focus on clinically driven innovation in cardiovascular therapies, aiming to demonstrate Chinese medtech competitiveness globally. Qiming Venture Partners, managing over $9.5 billion across US Dollar and RMB funds, has backed over 580 companies, with more than 210 exits via IPOs or M&A. The firm's investment thesis emphasizes China's advantages in clinical experience, engineering, supply chains, and entrepreneurship for global medtech products.
Apr-20Series BChina SDIC Gaoxin; Lotus Lake Ventures$28MInsight Lifetech is a leading Chinese innovative medical device manufacturer focused on intelligence-powered precision cardiovascular intervention, with its core product being the first independently-developed 60MHz high-definition high-speed IVUS system approved in China and the first China-made product approved by CE MDR, achieving the largest market share in China. The company filled critical gaps in China's high-performance precision cardiovascular interventional devices sector. The company is committed to transferring clinical insights into innovative therapies for cardiovascular intervention worldwide. Qiming Venture Partners led Insight Lifetech's C round financing in 2020 and participated in the subsequent D round, holding over 6% stake pre-IPO. Insight Lifetech successfully listed on the Shanghai Stock Exchange’s STAR Market on February 5, 2026, issuing shares at CNY17.52 per share, opening at CNY50.31, with a market capitalization of CNY20.98 billion. The IPO raised ¥998.64 million (US$143.93 million).

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Insight Lifetech

When was Insight Lifetech founded?Insight Lifetech was founded in 2015.
Where is Insight Lifetech headquartered?Insight Lifetech is headquartered in China.
Is Insight Lifetech publicly listed?Yes, Insight Lifetech is a public company listed on Shanghai Stock Exchange.
What is the stock symbol of Insight Lifetech?Insight Lifetech trades under 688712 ticker.
When did Insight Lifetech go public?Insight Lifetech went public in 2026.
Who are competitors of Insight Lifetech?Insight Lifetech main competitors include Amplifon, BGI Genomics, Mehow Innovative, Integer Holdings, Autobio Diagnostics, Carl Zeiss Meditec, GRAIL, 10x Genomics, Ambu, Double Medical Technology.
What is the current market cap of Insight Lifetech?Insight Lifetech's current market cap is $3B.
What is the current revenue of Insight Lifetech?Insight Lifetech's last fiscal year revenue is $80M.
What is the current EV/Revenue multiple of Insight Lifetech?Current revenue multiple of Insight Lifetech is 33.2x.
Is Insight Lifetech profitable?No, Insight Lifetech is not profitable.
How many companies Insight Lifetech has acquired to date?Insight Lifetech hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Insight Lifetech has invested to date?Insight Lifetech hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Insight Lifetech

Lists including Insight Lifetech

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial